In an increasingly challenging research funding climate, partnerships to share resources and leverage complementary expertise have never been more important, writes Mr. Michael Burton.
Does big data have a big problem? Dr. John W. Sweetenham cautions, "There is a real danger that we legitimize flawed data sets by labelling them as 'real-world data' when they neither reflect the real world...
As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as...
